HK1222452A1 - 評價慢性肝病的疾病嚴重性指標和診斷三種不同亞型的原發性硬化性膽管炎的方法 - Google Patents

評價慢性肝病的疾病嚴重性指標和診斷三種不同亞型的原發性硬化性膽管炎的方法

Info

Publication number
HK1222452A1
HK1222452A1 HK16110603.0A HK16110603A HK1222452A1 HK 1222452 A1 HK1222452 A1 HK 1222452A1 HK 16110603 A HK16110603 A HK 16110603A HK 1222452 A1 HK1222452 A1 HK 1222452A1
Authority
HK
Hong Kong
Prior art keywords
assessment
diagnosis
disease
chronic liver
sclerosing cholangitis
Prior art date
Application number
HK16110603.0A
Other languages
English (en)
Inventor
Gregory Thomas Everson
Steve Mark Helmke
Original Assignee
The Regents Of The Univ Of Colorado A Body C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Regents Of The Univ Of Colorado A Body C filed Critical The Regents Of The Univ Of Colorado A Body C
Publication of HK1222452A1 publication Critical patent/HK1222452A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/08—Hepato-biliairy disorders other than hepatitis
    • G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Primary Health Care (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK16110603.0A 2012-11-12 2016-09-06 評價慢性肝病的疾病嚴重性指標和診斷三種不同亞型的原發性硬化性膽管炎的方法 HK1222452A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261725292P 2012-11-12 2012-11-12
PCT/US2013/069708 WO2014075082A1 (en) 2012-11-12 2013-11-12 Disease severity index for assessment of chronic liver disease and method for diagnosis of three distinct subtypes of primary sclerosing cholangitis

Publications (1)

Publication Number Publication Date
HK1222452A1 true HK1222452A1 (zh) 2017-06-30

Family

ID=50685246

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16110603.0A HK1222452A1 (zh) 2012-11-12 2016-09-06 評價慢性肝病的疾病嚴重性指標和診斷三種不同亞型的原發性硬化性膽管炎的方法

Country Status (8)

Country Link
US (5) US9091701B2 (zh)
EP (1) EP2917727B1 (zh)
JP (1) JP6378194B2 (zh)
CN (1) CN105452857B (zh)
AU (1) AU2013341378B2 (zh)
CA (2) CA3191764A1 (zh)
HK (1) HK1222452A1 (zh)
WO (1) WO2014075082A1 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8778299B2 (en) 2005-01-26 2014-07-15 The Regents Of The University Of Colorado, A Body Corporate Methods for diagnosis and intervention of hepatic disorders
WO2006081521A2 (en) 2005-01-26 2006-08-03 The Regents Of The University Of Colorado Methods for diagnosis and intervention of hepatic disorders
US8961925B2 (en) 2011-05-31 2015-02-24 The Regents Of The University Of Colorado, A Body Corporate Method for assessment of hepatic function and portal blood flow
WO2014075082A1 (en) 2012-11-12 2014-05-15 Gregory Thomas Everson Disease severity index for assessment of chronic liver disease and method for diagnosis of three distinct subtypes of primary sclerosing cholangitis
US10622109B1 (en) * 2013-06-14 2020-04-14 Cerner Innovation, Inc. Method for monitoring mortality risk in children with tetralogy of fallot
US11340235B2 (en) * 2014-02-28 2022-05-24 Ga Generic Assays Gmbh GP2 isoforms and their use in autoantibody capture
US20150327121A1 (en) * 2014-05-08 2015-11-12 Guoqing C. Li Method, apparatus, and computer readable media for acknowledgement in wireless networks
JP2017014206A (ja) 2015-06-30 2017-01-19 ナノアンティバイオティクス，インコーポレイテッド 腹水の治療
CN110769741B (zh) * 2017-06-30 2023-05-02 佐治亚州立大学研究基金会 用于检测肝纤维化的非侵入性方法
RU2718325C2 (ru) * 2018-07-23 2020-04-01 Сергей Борисович Пономарёв Способ прогнозирования развития неалкогольной жировой болезни печени при висцеральном ожирении
EP3870964A4 (en) * 2018-10-19 2022-10-26 Avalon Hepapoc Limited SYSTEM FOR RAPID QUANTITATIVE DETERMINATION OF GALACTOSE AND ITS USE
CN110265139A (zh) * 2019-02-01 2019-09-20 中国医药大学附设医院 肝纤维化评估模型、肝纤维化评估系统及其评估方法
TWI685854B (zh) * 2019-02-01 2020-02-21 中國醫藥大學附設醫院 肝纖維化評估模型、肝纖維化評估系統及肝纖維化評估方法
EP3946359A1 (en) * 2019-03-26 2022-02-09 Intercept Pharmaceuticals, Inc. Methods of diagnosis and treatment of liver diseases using obeticholic acid
AU2021254287A1 (en) * 2020-04-09 2022-11-10 HepQuant, LLC Improved methods for evaluating liver function
WO2022016293A1 (en) * 2020-07-23 2022-01-27 Ottawa Heart Institute Research Corporation Health care resources management
US20220378786A1 (en) * 2021-05-21 2022-12-01 HepQuant, LLC Methods of defining functional change and slowing progression in chronic liver disease

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207308A (en) 1976-09-02 1980-06-10 The United States Of America As Represented By The Administrator Of Veterans Affairs Process for purifying iodinated bile acid conjugates
TW319763B (zh) 1995-02-01 1997-11-11 Epix Medical Inc
DE60029302T2 (de) 2000-04-28 2007-08-09 Bayer Ag Diagnose von Leberfibrose mit Hilfe von Serummarkeralgorithmen
CN100416273C (zh) 2000-08-21 2008-09-03 法国公立援助医院 采用生物化学标记物诊断纤维化疾病的方法
US7048907B2 (en) 2001-02-05 2006-05-23 Biophysics Assay Laboratory, Inc. Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products
US6778269B2 (en) 2001-09-04 2004-08-17 Board Of Regents, The University Of Texas System Detecting isotopes and determining isotope ratios using raman spectroscopy
WO2006081521A2 (en) 2005-01-26 2006-08-03 The Regents Of The University Of Colorado Methods for diagnosis and intervention of hepatic disorders
US8778299B2 (en) 2005-01-26 2014-07-15 The Regents Of The University Of Colorado, A Body Corporate Methods for diagnosis and intervention of hepatic disorders
US20060251576A1 (en) 2005-05-03 2006-11-09 The Regents Of The University Of California Methods for measuring cholesterol metabolism and transport
GB0617581D0 (en) * 2006-09-07 2006-10-18 Ucl Business Plc Biomarkers for assessing liver function
BRPI1008488A2 (pt) * 2009-02-26 2017-05-30 Ct Hospitalier Universitaire D Angers diagnóstico melhorado de fibrose ou cirrose do fígado
JP6163479B2 (ja) * 2011-04-14 2017-07-12 エクサレンズ バイオサイエンス リミテッド 肝細胞癌の診断、予後診断、監視および治療方法
US8961925B2 (en) 2011-05-31 2015-02-24 The Regents Of The University Of Colorado, A Body Corporate Method for assessment of hepatic function and portal blood flow
WO2014075082A1 (en) 2012-11-12 2014-05-15 Gregory Thomas Everson Disease severity index for assessment of chronic liver disease and method for diagnosis of three distinct subtypes of primary sclerosing cholangitis
WO2021006949A1 (en) 2019-07-10 2021-01-14 Hrl Laboratories, Llc Action classification using deep embedded clustering

Also Published As

Publication number Publication date
AU2013341378A1 (en) 2015-05-28
US20190339294A1 (en) 2019-11-07
CN105452857A (zh) 2016-03-30
CN105452857B (zh) 2019-06-28
CA2891281C (en) 2023-11-28
EP2917727B1 (en) 2018-01-10
CA2891281A1 (en) 2014-05-15
AU2013341378B2 (en) 2018-02-01
US10520517B2 (en) 2019-12-31
US20150268255A1 (en) 2015-09-24
EP2917727A4 (en) 2016-06-22
US9091701B2 (en) 2015-07-28
WO2014075082A1 (en) 2014-05-15
JP2016504571A (ja) 2016-02-12
US9759731B2 (en) 2017-09-12
EP2917727A1 (en) 2015-09-16
US20140147875A1 (en) 2014-05-29
JP6378194B2 (ja) 2018-08-22
US20220034915A1 (en) 2022-02-03
CA3191764A1 (en) 2014-05-15
US20180024153A1 (en) 2018-01-25
US11181536B2 (en) 2021-11-23

Similar Documents

Publication Publication Date Title
HK1222452A1 (zh) 評價慢性肝病的疾病嚴重性指標和診斷三種不同亞型的原發性硬化性膽管炎的方法
HK1212022A1 (zh) 預測患高血壓風險的方法
FR2977046B1 (fr) Diagnostic perfectionne pour aeronefs
HK1210782A1 (zh) 抑制劑及其多晶型物
PT2939022T (pt) Biomarcadores de nascimento prematuro
BR112014009521A2 (pt) aplicativos de navegação que usam um touchpad montado em uma lateral
BR112013020220A2 (pt) métodos para determinação de ploidia pré-natal não invasiva
PT2748605T (pt) Processos e composições para o diagnóstico e o prognóstico de lesões renais e de insuficiência renal
HK1204016A1 (zh) 用於對具有患癌風險的受試者進行檢查的方法和成套器具
EP2788759A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSING AND PROGNOSING KIDNEY INJURY AND RENAL FAILURE
EP2834638A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF A SEPSIS
EP2814728A4 (en) USE OF A CENTRAL MOTOR FOR ACCOSTAGE
IL227311A0 (en) Risk calculation for fetal aneuploidy note
EP2729803A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSING AND PROGNOSING RENAL INJURY AND RENAL FAILURE
EP2661626A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency
EP2783213A4 (en) METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
PL2864497T3 (pl) Metody wykonywania oznaczeń ilościowych
SG11201405861UA (en) Surface treatment for corrosion resistance of aluminum
EP2810072A4 (en) COMPOSITION AND METHODS FOR THE HIGHLIGHTING OF METABOLITE METHADONE
DK2745928T3 (da) Fremgangsmåde til emulsionsfremstilling
HK1204339A1 (zh) 用於腎損傷和腎衰竭的診斷及預後的方法和組合物
EP2875347A4 (en) METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF SEPSIS
HK1207155A1 (zh) 用於腎損傷和腎衰竭的診斷及預後的方法和組合物
HK1203620A1 (zh) 用於腎損傷和腎衰竭的診斷及預後的方法和組合物
SI2856079T1 (sl) Določanje debeline sloja